Esophageal Motility and Rikkunshito Treatment for Proton Pump Inhibitor-Refractory Nonerosive Reflux Disease: A Prospective, Uncontrolled, Open-Label Pilot Study Trial
Background: Only a few reports focused on esophageal motility in patients with proton pump inhibitor (PPI)-refractory nonerosive reflux disease (NERD) and there has been no established strategy for treatment. Objective: To clarify the characteristics of esophageal motility in patients with PPI-refra...
Main Authors: | Takeo Odaka, MD, PhD, Shigeru Yamato, MD, PhD, Osamu Yokosuka, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-01-01
|
Series: | Current Therapeutic Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0011393X1730019X |
Similar Items
-
Open Label Trial of the Efficacy and Safety Profile of Rikkunshito used for the Treatment of Gastrointestinal Symptoms in Patients with Parkinson’s Disease: A Pilot Study
by: Koji Yakabi, MD, PhD, et al.
Published: (2017-01-01) -
Rikkunshito as a Therapeautic Agent for Functional Dyspepsia and its Prokinetic and Non-Prokinetic Effects
by: Kazumi Inokuchi, et al.
Published: (2021-06-01) -
Ghrelin Enhancer, the Latest Evidence of Rikkunshito
by: Chihiro Yamada, et al.
Published: (2021-12-01) -
Esophageal Motility Disorders in patients with Gastro-Esophageal Reflux Disease diagnosed by using High Resolution Esophageal Manometry- data from the developing world
by: Zain Majid, et al.
Published: (2021-10-01) -
Rikkunshito, a ghrelin potentiator, ameliorates anorexia-cachexia syndrome
by: Naoki eFujitsuka, et al.
Published: (2014-12-01)